Tuesday, December 31, 2019 8:41:09 AM
But if i can take a nice profit and just can get some of my initial back i want hesitate to do so.
But i re evaluate my position every month ,if company can execute according to there plan i can also see double figures next year.
More positives then negatives.
Denis didn't replied to my e-mail and that he isn't communicating about the QBM-001- QBM -002 is for me on the list of small negatives .
Things he better do not do is promotion like proactive investors and Litchfield hills is useless for the company ,only cost money .
You could argue about his timelines ,if he delivers in the end i'm ok, with that.
Also don't want to see financing like we had in November below $1
But if everything falls into place this one is poised to be the next ARWR or AXSM.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM